COSAN S.A. (CSAN): what the price assumes

boothcheck covers COSAN S.A. (CSAN) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/CSAN

Headline

FieldValue
TickerCSAN
CompanyCOSAN S.A.
Sector / IndustryConsumer Cyclical
Current price$3.04/sh
CompositionInitial quote 0% / Closing quote 0% / Daily average quote 0% / High quote 0% / Low quote 0% / Monthly average quote 100%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)5.8%
Operating margin today17.5%
Margin compression (value-band)-11.7pp
Multiple paid8x operating income

The operating-margin figure is value-band context at year 7: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 4.7% sits below it).

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.68σ
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.20x3justifies
Earnings1.41x1expensive
Relative0
Growth0.83x3justifies

Families that justify the price: Asset, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.3%); the inversion above states its own rate.

Per-Model Detail (n=7)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noNegative/zero FCF — equity value floored at $0
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelativenoP/S fallback (negative EPS): Sector P/S 1.5x × TTM revenue — excluded from consensus
Simple DDMGrowth$3.090.98xyesDPS $1.17, g=-20.7% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$41.410.07xyesStage 1: 20% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$16.550.18xyesBook value floor: BV/sh $16.55, ROE negative
Two-Stage Excess ReturnAsset$14.900.20xyesBook value with convergence: BV/sh $16.55, ROE converges to ke
Discounted Future Market CapGrowth$3.650.83xyesRev $8.6B, growth 23% (input: historical growth; tapered), Terminal P/S: 0.1x / 0.2x / 0.2x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthnoMargin ramp: -19% → 12% over 7yr, rev growth 23% (input: historical growth; tapered)
Earnings Power ValueEarnings$2.161.41xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.32B × (1−21%) / WACC 7.4% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $2.27B × sector EV/EBITDA 14.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAsset$12.850.24xyesBV $16.55 × (ROIC 5.7% / WACC 7.4%)
P/Sales SectorRelativenoRevenue $8.62B × sector P/S 1.5x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Initial quoteoperatingenterprise0.0B reported-currencywithheldunresolved no unit value
Closing quoteoperatingenterprise0.0B reported-currencywithheldunresolved no unit value
Daily average quoteoperatingenterprise0.0B reported-currencywithheldunresolved no unit value
High quoteoperatingenterprise0.0B reported-currencywithheldunresolved no unit value
Low quoteoperatingenterprise0.0B reported-currencywithheldunresolved no unit value
Monthly average quoteoperatingenterprise0.5B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$9.6b
Net debt / NOPAT (after-tax)8.16x
Net debt / operating income (pre-tax)6.45x
Interest coverage1.0x
Burning cashno

Bullet Takeaways

Bull Case

Start with what a buyer actually owns. Cosan does not run one business so much as hold several, and the largest of them trade in their own right: the sugar and ethanol venture Raízen has been listed on Brazil's exchange since August 2021, the rail operator Rumo since 2015, and the gas distributor Comgás since 1997, all disclosed in the annual filing. What trades in New York is the residual left after the debt at the top of that structure is served. It is a thin slice of a large balance sheet, and it moves like one.

The operations underneath are not small. Counted at one hundred percent, the sugar and ethanol venture booked net sales of 228,802.0 million reais in 2025, a figure that comes down from the prior year and is still an order of magnitude larger than the holding company's own market value. Beside it sits a fuels and lubricants business the filing describes as supplying a network of service stations, airport refueling sites and business-to-business customers in Brazil, Paraguay and Argentina, plus Moove, which formulates and distributes lubricants. These are physical positions in a country that needs sugar crushed, grain moved and gas piped whether or not the equity market is paying attention.

Capital allocation is where the case actually lives, and one disclosure carries more of it than any operating metric. The filing states that Our secured debt as of December 31, 2025 represented 10.8% of our total debt. Almost nine tenths of the group's lenders therefore hold unsecured paper against stakes that have public prices and can be sold. That is the difference between a company that must negotiate with a bank before it does anything and one that can raise cash by trimming a position. Management has been doing exactly that: talks involving Shell and BTG over a capital deal for the sugar venture were reported to be advancing earlier this year.

Now the price. Book value stands at 16.55 dollars a share. The stock changed hands at $3.01. A discount that wide is not a mispricing waiting to be noticed, and the bear is right that a balance sheet earning its interest and not much more deserves to trade below book. The bull answer is narrower and, for once, arithmetic rather than aspirational. Most of this group's borrowing is in local currency, so the cost of it moves with Brazilian policy rates rather than with anything happening in the sugar market. Rates do not have to collapse for that to matter. They have to stop rising. When the residual claim is this small relative to the debt in front of it, a few points off the average cost of the book is the difference between an equity that earns nothing and one that earns something, and the something arrives without a single extra tonne of cane being crushed.

Bear Case

Nobody buying this at three dollars a share is paying for growth, which means the usual bear argument is unavailable. The price embeds no expansion story to puncture. What it does embed is a dependency, and it is a narrow one: the whole thesis rests on the cost of money in Brazil, a variable the company does not set, does not forecast publicly, and cannot hedge away at this size.

The 2025 finance line shows why. Net finance expense for the year came to 7,791.4 million reais, and against that the group's operating profit covers its interest roughly one turn over. One turn means the operating businesses are, in practical terms, working for the lenders. Whatever survives that then passes through subsidiaries where outside shareholders take their cut before anything reaches the parent. It also means the sensitivity runs the wrong way: at one turn of coverage, a rise in the average cost of the book does not compress the residual, it removes it.

The lenders have already been consulted about this once. The eleventh through fourteenth debenture issuances contain a contractual leverage covenant limited to 3.0 x, and the filing adds that they benefit from a pre-approved waiver permitting the issuer to exceed this ratio up to 3.5 x through December 31, 2027. A pre-approved waiver is a useful thing to have and an uncomfortable thing to need. It also carries a date, which converts an open-ended leverage question into a scheduled one with roughly eighteen months on the clock.

Management's own account of the growth plan closes the loop. The filing states that to implement its strategy we may need to finance new investments through additional indebtedness, and warns that unfavorable conditions in Brazil and in international credit markets may limit that access. A company whose main earnings pressure is the cost of debt, and whose growth plan is funded with debt, has fewer routes out than its asset list suggests. Nor is the underlying volume story doing the work: the sugar and ethanol venture's net sales fell to 228,802.0 million reais in 2025 from 251,198.8 million reais in 2024, so the recent trend in the biggest asset is down.

One valuation lens already agrees with all of this, and it happens to be the least forgiving one. Capitalize the group's average operating profit and credit it with no growth whatsoever, and the value that falls out sits below the market price: today's price is about 38% above where the earnings-power methods land. Everything above that figure is an argument about assets rather than about earnings, which is a different and slower thing to realize. The downside is not zero, because roughly 2.06 billion dollars of equity stakes sit outside the operating businesses, more than the entire company is worth in the market. But those stakes sit on the same balance sheet that carries about 9.58 billion dollars of net debt. They bound the fall. They do not cushion it.

Valuation

Take today's price as given and ask what it assumes. At $3.01 the market is asking this company for nothing at all. The price sits below what even a business shrinking its operating profit by about 5% a year would warrant, and that is a bound rather than a forecast: it says the assumption embedded in the price is somewhere past ordinary decline, not that decline is scheduled. For a group that includes a listed rail operator and a listed gas utility, that is an unusual thing for a price to be saying.

The methods used to triangulate value mostly disagree with the market, and they disagree in the same direction. The asset-value lens, anchored on reported book value, lands well above the current price. The peer-multiple methods land further above still, though that reading deserves a caveat rather than applause: they reach their answer by applying sector-wide yardsticks to consolidated group revenue, and a holding company whose subsidiaries carry their own debt and their own minority shareholders is precisely the case where that arithmetic flatters. The cash-flow methods also land above the price. Only the earnings-power lens comes in below it, and the price sits about 38% above where those earnings-power methods land.

So the concrete question is not what margin the business has to reach. It is whether the capital structure leaves shareholders anything to own. Net debt runs about 6.45 times operating profit and interest coverage sits at roughly one turn, which together describe a business that currently earns its interest bill and very little beyond it. The equity is what remains after that, which is why the whole company carries a market value of about 1.4 billion dollars against borrowings several times larger.

The shape of those borrowings is the last piece, and it is the piece that decides how the equity behaves. The filing reports that Debt denominated in U.S. dollars represented 27.86%, debt denominated in euros represented 0.03%, and debt denominated in pounds sterling represented 0.4% of our total debt, which leaves the clear majority of the book in reais, repricing with local rates. Liquid assets of roughly 3.27 billion dollars sit against gross borrowings of roughly 12.85 billion, and the filing states that Our secured debt as of December 31, 2025 represented 10.8% of our total debt. Stable assets, a volatile liability, and the difference between them is what the share price measures. The residual a buyer picks up here will be resized by the cost of that debt long before it is resized by the volume of sugar, freight or gas moving through the group.

Catalysts

The next dated event is the second-quarter report, scheduled for August 13, 2026. The first quarter, reported on May 15, 2026, carried a net loss of 1.6 billion reais, an improvement on the same quarter a year earlier. On the accompanying call management put debt reduction and deleveraging at the center of the agenda. Given that the finance line rather than the operating line is what moves this equity, the interest expense figure in August is the number that matters more than revenue.

Analyst opinion has moved twice this year and both moves turned on the same variable. HSBC cut its rating to Reduce from Hold in May, citing higher financial expenses. Citi resumed coverage at Neutral in late June, with the stated view that the company depends on Brazilian interest rate cuts. Neither is a fundamental judgment about sugar, rail or gas volumes. Both are judgments about the cost of the debt, which is a reasonable summary of what this equity currently is.

The structural item to watch is the capital arrangement for the sugar and ethanol venture involving Shell and BTG, reported as advancing earlier in the year. Anything that injects capital into that venture changes the parent's ownership percentage and its funding obligations at the same time, and those two effects do not necessarily point the same way for the holding company's shareholders.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

company earnings calendar via stockanalysis.com, July 2026 · stockanalysis.com news listing, February 2026 · Q1 2026 results summary via stockanalysis.com, May 2026 · Q1 2026 earnings call coverage, May 2026 · HSBC rating change, May 2026 · Citi coverage resumption, June 2026

View the full interactive CSAN report on boothcheck